FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Sunday, June 3, 2018
FDA wants to shorten new drug monopolies to cut costs
FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Related Posts:
German state ready to buy company stakes to protect core industry- Wall Street rises at open, lifted by upbeat earnings
- Facebook's Zuckerberg is on offense to reshape what's been tremendous negative sentiment: Patriarch Organization CEO
- Stocks sizzle at 2-month high before Trump State of the Union address
- Viacom's Netflix deal highlights content strategy; earnings mixed
0 comments:
Post a Comment